Epidarex invests in early-stage,
high growth life science and health technology companies
in emerging and under-ventured research hubs within the UK and US

Epidarex Provides Equity Capital to Start-Ups, Including University Spin-outs

Through our deep scientific and industry network we are able to identify transformative life science investments in under-ventured regions of the US and UK, building companies from scratch to create value and shared success.

Our international management team has a track record of successfully partnering with scientists and entrepreneurs to develop highly innovative products for the global healthcare market. We leverage our extensive relationships, industry operating experience and a disciplined investment approach to add significant value to our portfolio companies and to generate strong returns on investment for our investors.

We believe in working closely with the management of our portfolio companies to drive the translation of their research into world-class businesses.

Our global network includes investment professionals, scientists, industry executives, health practitioners, policy experts, regulatory advisors and business development leaders. This strong network contributes significantly to the growth and development of our portfolio companies.


The EpidarEx Team

Experienced Professionals

A. Sinclair Dunlop

Managing Partner

Kyparissia Sirinakis

Managing Partner

Elizabeth Roper Ph.D.

General Partner

Peter Finan Ph.D.

General Partner

Mary Canning Ph.D.


Lori Krim Gough Ph.D.


Terri Burke

Venture Partner

Henning Steinhagen Ph.D.

Venture Partner

Anthony Voveris

Vice President of Finance

Mathew Miessau


Melissa Lezameta Ph.D.


Victor Pong Ph.D.

Senior Analyst

Alvin Lewis

Staff Accountant

Bridget Harris

Operations Manager

Megan MacDougall

Executive Assistant